Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 14770

1.

Regulation of differentiation of MEG01 to megakaryocytes and platelet-like particles by Valproic acid through Notch3 mediated actin polymerization.

Dhenge A, Kuhikar R, Kale V, Limaye L.

Platelets. 2018 Oct 17:1-16. doi: 10.1080/09537104.2018.1528344. [Epub ahead of print]

PMID:
30332548
2.

Accuracy of Valproic Acid Concentration Correction Based on Serum Albumin.

Drisaldi A, Weeda E, Neyens R, Orvin N, Bonilha L, Campbell Z, Bohm N.

Neurocrit Care. 2018 Oct 16. doi: 10.1007/s12028-018-0627-4. [Epub ahead of print]

PMID:
30328046
3.

Teratogenicity of valproic acid and its constitutional isomer, amide derivative valnoctamide in mice.

Lin YL, Bialer M, Cabrera RM, Finnell RH, Wlodarczyk BJ.

Birth Defects Res. 2018 Oct 16. doi: 10.1002/bdr2.1406. [Epub ahead of print]

PMID:
30325584
4.

Therapeutic monitoring of antiepileptic drugs in comatose patients.

Charfi R, Mizouri R, Ben Sassi M, Eljebari H, Jebabli N, Ben Salem F, Zerei S, Mrabet A, Daghfous R, Klouz A, Salouage I, Gaies E, Trabelsi S.

Tunis Med. 2018 Feb;96(2):129-134.

PMID:
30324978
5.

Neuroprotective effect of baicalin on focal cerebral ischemia in rats.

Dai J, Qiu YM, Ma ZW, Yan GF, Zhou J, Li SQ, Wu H, Jin YC, Zhang XH.

Neural Regen Res. 2018 Dec;13(12):2129-2133. doi: 10.4103/1673-5374.241464.

PMID:
30323141
6.

Synergistic antitumor activity of oridonin and valproic acid on HL-60 leukemia cells.

Li W, Ma L.

J Cell Biochem. 2018 Oct 15. doi: 10.1002/jcb.27845. [Epub ahead of print]

PMID:
30320906
7.

Age-Dependent Anti-migraine Effects of Valproic Acid and Topiramate in Rats.

Huang P, Kuo PH, Lee MT, Chiou LC, Fan PC.

Front Pharmacol. 2018 Sep 25;9:1095. doi: 10.3389/fphar.2018.01095. eCollection 2018.

8.

Phenotypic Reprogramming of Striatal Neurons into Dopaminergic Neuron-like Cells in the Adult Mouse Brain.

Niu W, Zang T, Wang LL, Zou Y, Zhang CL.

Stem Cell Reports. 2018 Sep 28. pii: S2213-6711(18)30389-8. doi: 10.1016/j.stemcr.2018.09.004. [Epub ahead of print]

9.

Bipolar Disorder Mixed Episodes: A Pragmatic Trial of a Public Health Treatment Effectiveness.

Miguel SRPS, Lima AFBS, Cruz LN, Cohen M, Zimmermann JJ, Ziegelmann PK, Fleck MPA.

Value Health Reg Issues. 2018 Oct 10;17:158-163. doi: 10.1016/j.vhri.2018.07.004. [Epub ahead of print]

PMID:
30316147
10.

Current Treatment Strategies and Future Treatment Options for Dravet Syndrome.

Ziobro J, Eschbach K, Sullivan JE, Knupp KG.

Curr Treat Options Neurol. 2018 Oct 13;20(12):52. doi: 10.1007/s11940-018-0537-y. Review.

PMID:
30315507
11.

Association study between inwardly rectifying potassium channels 2.1 and 4.1 and autism spectrum disorders.

Sun C, Zou M, Li L, Li D, Ma Y, Xia W, Wu L, Ren H.

Life Sci. 2018 Oct 7. pii: S0024-3205(18)30629-5. doi: 10.1016/j.lfs.2018.10.012. [Epub ahead of print]

PMID:
30304693
12.

Effect of valproic acid alone or combined with low dose gamma irradiation in modulating PTZ-induced convulsions in rats involving AKT/m-TOR pathway.

Lotfy DM, Safar MM, Mohamed SH, Kenawy SA.

Life Sci. 2018 Oct 6. pii: S0024-3205(18)30624-6. doi: 10.1016/j.lfs.2018.10.007. [Epub ahead of print]

PMID:
30300655
13.

Effects of Valproic Acid on Cerebral Nutrient Carriers' Expression in the Rat.

Mann Brukner A, Ben-Hur T, Honig A, Ekstein D, Eyal S.

Front Pharmacol. 2018 Sep 21;9:1054. doi: 10.3389/fphar.2018.01054. eCollection 2018.

14.

Mood stabilisers and risk of stroke in bipolar disorder.

Chen PH, Tsai SY, Pan CH, Chang CK, Su SS, Chen CC, Kuo CJ.

Br J Psychiatry. 2018 Oct 8:1-6. doi: 10.1192/bjp.2018.203. [Epub ahead of print]

PMID:
30295208
15.

Ictal Source Locations and Cortico-Thalamic Connectivity in Childhood Absence Epilepsy: Associations with Treatment Response.

Miao A, Wang Y, Xiang J, Liu Q, Chen Q, Qiu W, Liu H, Tang L, Gao Y, Wu C, Yu Y, Sun J, Jiang W, Shi Q, Zhang T, Hu Z, Wang X.

Brain Topogr. 2018 Oct 5. doi: 10.1007/s10548-018-0680-5. [Epub ahead of print]

PMID:
30291582
16.

The critical interaction between valproate sodium and warfarin: case report and review.

Zhou C, Sui Y, Zhao W, Dong C, Ren L, Song P, Xu B, Sun X.

BMC Pharmacol Toxicol. 2018 Oct 1;19(1):60. doi: 10.1186/s40360-018-0251-0.

17.

N-(2'-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells.

de Oca AC, Valle ER, Hernández MCR, Rojano EA, Hernández SR, Vázquez MJF, Wejebe JEM, Basurto AMC, Moctezuma IV, Basurto JC.

Oncotarget. 2018 Sep 7;9(70):33368-33381. doi: 10.18632/oncotarget.26077. eCollection 2018 Sep 7.

18.

High incidence of persistent subtherapeutic levels of the most common AEDs in children with epilepsy receiving polytherapy.

Czornyj L, Cáceres Guido P, Bramuglia G, Rodiño A, Feria-Romero I, Lazarowski A.

Epilepsy Res. 2018 Sep 22. pii: S0920-1211(18)30326-7. doi: 10.1016/j.eplepsyres.2018.09.008. [Epub ahead of print]

PMID:
30279018
19.

An opportunity for clinical pharmacology trained physicians to improve patient drug safety: A retrospective analysis of adverse drug reactions in teenagers.

Eugene AR, Eugene B.

Version 2. F1000Res. 2018 May 30 [revised 2018 Jan 1];7:677. doi: 10.12688/f1000research.14970.2. eCollection 2018.

20.

Immunocytochemical analysis of valproic acid induced histone H3 and H4 acetylation during differentiation of rat adipose derived stem cells into neuron-like cells.

Rezaei F, Tiraihi T, Abdanipour A, Hassoun HK, Taheri T.

Biotech Histochem. 2018 Oct 1:1-12. doi: 10.1080/10520295.2018.1511063. [Epub ahead of print]

PMID:
30273059

Supplemental Content

Loading ...
Support Center